HOME Top Market Reports qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020

qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020

By: marketsandmarkets.com
Publishing Date: January 2016
Report Code: BT 3999

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The Global qPCR reagents market is poised to reach ~USD 1,893.9 Million by 2020 From USD 1,307.0 Million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.

North America (particularly the U.S.) is expected to hold the largest share of qPCR reagents market during the forecast period. Factors such as high penetration of qPCR technologies among key end users, increasing public & private funding to expand the application base of qPCR, ongoing product advancements in the field of qPCR reagents, and continuous reduction in the average cost of genome sequencing are driving the growth of the North American market.

In 2014, Thermo Fisher Scientific (U.S.) dominated the global qPCR reagents market. Over the past three years, the company adopted product commercialization, agreements, collaborations, geographic expansion, and awareness campaigns as key business strategies to maintain its position in the market. The other key players in this market include Bio-Rad Laboratories Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche, Ltd. (Switzerland), Agilent Technologies Inc. (U.S.), Takara Bio (Japan), Affymetrix Inc. (U.S.), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), and Quanta Biosciences Inc. (U.S.), among others.

Scope of the Report

This research report categorizes the global market into the following segments and subsegments:

qPCR Reagents Market, By Detection Method

  • Dye-based Reagents
  • Probe & Primer-based Reagents

qPCR Reagents Market, By packaging Method

  • qPCR Core Kits
  • qPCR Mastermixes

qPCR Reagents Market, By End User

  • Hospitals and Diagnostic Centers
  • Research Laboratories and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Research Organizations
  • Forensic Laboratories

qPCR Reagents Market, By Application

  • Diagnostic
  • Research
  • Forensic

qPCR Reagents Market, By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Study Objectives
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Factor Analysis
           2.2.1 Introduction
           2.2.2 Demand-Side Analysis
                    2.2.2.1 Healthcare Expenditure Patterns
                    2.2.2.2 Rapid Growth of Aging Population
                    2.2.2.3 Incidence and Prevalence of Cancer
                    2.2.2.4 Birth Rate/Pregnancies
                    2.2.2.5 Burden of Infectious Diseases
                    2.2.2.6 Number of Clinical, Forensic, and Research Laboratories
           2.2.3 Supply-Side Analysis
                    2.2.3.1 Number of New Product Launches: qPCR Reagents vs. Competitive Technologies
                    2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions
           2.5.1 Assumptions

3 Executive Summary (Page No. - 34)
    3.1 Introduction
    3.2 History, Evolution, and Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 39)
    4.1 Global qPCR Reagents Market (2015–2020)
    4.2 Global Market Size, By Detection Method (2015 vs. 2020)
    4.3 Global Market Share, By Packaging Type (2015)
    4.4 Global Market Size, By Application (2015)
    4.5 Global Market Size, By End User (2015 vs. 2020)

5 Market Overview (Page No. - 44)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Key Market Drivers
                    5.3.1.1 Rising Incidence of Infectious Diseases and Genetic Disorders
                    5.3.1.2 Growing Geriatric Population
                    5.3.1.3 Technological Advancements
                    5.3.1.4 Increasing Public-Private Investments, Funds, and Grants
                    5.3.1.5 Successful Completion of the Human Genome Project
           5.3.2 Key Market Restraints
                    5.3.2.1 Technical Limitations Associated With qPCR
           5.3.3 Key Market Opportunities
                    5.3.3.1 Growing Market Penetration in Emerging Countries
                    5.3.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
           5.3.4 Key Market Challenges
                    5.3.4.1 Adoption and Implementation of Miqe Guidelines for Publishing qPCR-Based Research

6 Industry Trends (Page No. - 53)
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Supply Chain Analysis
    6.4 Industry Trends
    6.5 Porter’s Five Forces Analysis
           6.5.1 Threat From New Entrants
           6.5.2 Threat From Substitutes
           6.5.3 Bargaining Power of Suppliers
           6.5.4 Bargaining Power of Buyers
           6.5.5 Intensity of Competitive Rivalry

7 qPCR Reagents Market, By Detection Method (Page No. - 58)
    7.1 Introduction
    7.2 Dye-Based qPCR Reagents
    7.3 Probes and Primer-Based qPCR Reagents

8 qPCR Reagents Market, By Packaging Type (Page No. - 62)
    8.1 Introduction
    8.2 qPCR Core Kits
    8.3 qPCR Mastermixes

9 qPCR Reagents Market, By End User (Page No. - 67)
    9.1 Introduction
    9.2 Hospitals & Diagnostic Centers
    9.3 Research Laboratories & Academic Institutes
    9.4 Pharmaceutical & Biotechnology Companies
    9.5 Clinical Research Organizations (Cros)
    9.6 Forensic Laboratories

10 qPCR Reagents Market, By Application (Page No. - 74)
     10.1 Introduction
     10.2 Diagnostic Applications
     10.3 Research Applications
     10.4 Forensic Applications

11 qPCR Reagents Market, By Region (Page No. - 79)
     11.1 Introduction
     11.2 North America
              11.2.1 U.S.
              11.2.2 Canada
     11.3 Europe
              11.3.1 Germany
              11.3.2 U.K.
              11.3.3 France
              11.3.4 Rest of Europe (RoE)
     11.4 Asia-Pacific
              11.4.1 Japan
              11.4.2 China
              11.4.3 India
              11.4.4 Rest of Asia-Pacific (RoAPAC)
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 107)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Scenario
     12.4 Recent Developments
              12.4.1 New Product Launches and Product Approvals
              12.4.2 Agreements, Collaborations, and Partnerships
              12.4.3 Mergers, Demergers, and Acquisitions
              12.4.4 Expansion

13 Company Profiles (Page No. - 114)
     13.1 Introduction
              13.1.1 Geographic Benchmarking
              13.1.2 Strategic Benchmarking
                         13.1.2.1 Product Development and Commercialization
     13.2 Thermo Fisher Scientific Inc.
              13.2.1 Business Overview
              13.2.2 Products Offered
              13.2.3 Recent Developments
              13.2.4 MnM Overview
     13.3 Bio-Rad Laboratories, Inc.
              13.3.1 Business Overview
              13.3.2 Products Offered
              13.3.3 Recent Developments
              13.3.4 MnM Overview
     13.4 F. Hoffman-La Roche Ltd.
              13.4.1 Business Overview
              13.4.2 Products Offered
              13.4.3 Recent Developments
              13.4.4 MnM Overview
     13.5 Qiagen N.V.
              13.5.1 Business Overview
              13.5.2 Products Offered
              13.5.3 Recent Developments
              13.5.4 MnM Overview
     13.6 Agilent Technologies, Inc.
              13.6.1 Business Overview
              13.6.2 Products Offered
              13.6.3 Recent Developments
              13.6.4 MnM Overview
     13.7 Takara Bio Inc.
              13.7.1 Business Overview
              13.7.2 Products Offered
              13.7.3 Recent Developments
     13.8 Affymetrix, Inc.
              13.8.1 Business Overview
              13.8.2 Products Offered
              13.8.3 Recent Developments
     13.9 Sigma-Aldrich Corporation (A Subsidiary of Merck Kgaa, Germany)
              13.9.1 Business Overview
              13.9.2 Products Offered
              13.9.3 Recent Developments
     13.10 Promega Corporation
              13.10.1 Business Overview
              13.10.2 Products Offered
              13.10.3 Recent Developments
     13.11 Quanta Biosciences, Inc.
              13.11.1 Business Overview
              13.11.2 Products Offered
              13.11.3 Recent Developments

14 Appendix (Page No. - 150)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Introducing RT: Real Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports


List of Tables (69 Tables)

Table 1 qPCR Reagents Industry Focuses on Technological Integration to Develop Advanced Products With Diverse Application Areas
Table 2 Size, By Detection Method, 2013–2020 (USD Million)
Table 3 Dye-Based qPCR Reagents Market Size, By Region, 2013–2020 (USD Million)
Table 4 Probes & Primer-Based qPCR Reagents Market Size, By Region, 2013–2020 (USD Million)
Table 5 Market Size, By Packaging Type, 2013–2020 (USD Million)
Table 6 Market Size for Core Kits, By Region, 2013–2020 (USD Million)
Table 7 Market Size for Master mixes, By Region, 2013–2020 (USD Million)
Table 8 Global Market Size, By End User, 2013-2020 (USD Million)
Table 9 Market Size for Hospitals & Diagnostic Centers, By Region, 2013-2020 (USD Million)
Table 10 Market Size for Research Laboratories and Academic Institutes, By Region, 2013-2020 (USD Million)
Table 11 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 (USD Million)
Table 12 Market Size for CROS, By Region, 2013-2020 (USD Million)
Table 13 Market Size for Forensic Laboratories, By Region, 2013-2020 (USD Million)
Table 14 Global Market Size, By Application, 2013-2020 (USD Million)
Table 15 Market Size for Diagnostic Applications, By Region, 2013-2020 (USD Million)
Table 16 Market Size for Research Applications, By Region, 2013-2020 (USD Million)
Table 17 Market Size for Forensic Applications, By Region, 2013-2020 (USD Million)
Table 18 Market Size, By Region, 2013-2020 (USD Million)
Table 19 North America: Market Size, By Country, 2013-2020 (USD Million)
Table 20 U.S.: Market Size, By Detection Method, 2013-2020 (USD Million)
Table 21 U.S.: Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 22 U.S.: Market Size, By End User, 2013-2020 (USD Million)
Table 23 U.S.: Market Size, By Application, 2013-2020 (USD Million)
Table 24 Canada: Market Size, By Detection Method, 2013-2020 (USD Million)
Table 25 Canada: Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 26 Canada: Market Size, By End User, 2013-2020 (USD Million)
Table 27 Canada: Market Size, By Application, 2013-2020 (USD Million)
Table 28 Europe: Market Size, By Country, 2013-2020 (USD Million)
Table 29 Germany: Market Size, By Detection Method, 2013-2020 (USD Million)
Table 30 Germany: Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 31 Germany: Market Size, By End User, 2013-2020 (USD Million)
Table 32 Germany: Market Size, By Application, 2013-2020 (USD Million)
Table 33 U.K.: Market Size, By Detection Method, 2013-2020 (USD Million)
Table 34 U.K.: Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 35 U.K.: Market Size, By End User, 2013-2020 (USD Million)
Table 36 U.K.: Market Size, By Application, 2013-2020 (USD Million)
Table 37 France: Market Size, By Detection Method, 2013-2020 (USD Million)
Table 38 France: Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 39 France: Market Size, By End User, 2013-2020 (USD Million)
Table 40 France: Market Size, By Application, 2013-2020 (USD Million)
Table 41 RoE: Market Size, By Detection Method, 2013-2020 (USD Million)
Table 42 RoE: Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 43 RoE: Market Size, By End User, 2013-2020 (USD Million)
Table 44 RoE: Market Size, By Application, 2013-2020 (USD Million)
Table 45 Asia-Pacific Market Size, By Country, 2013-2020 (USD Million)
Table 46 Japan: qPCR Reagents Market Size, By Detection Method, 2013-2020 (USD Million)
Table 47 Japan: qPCR Reagents Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 48 Japan: qPCR Reagents Market Size, By End User, 2013-2020 (USD Million)
Table 49 Japan: qPCR Reagents Market Size, By Application, 2013-2020 (USD Million)
Table 50 China: qPCR Reagents Market Size, By Detection Method, 2013-2020 (USD Million)
Table 51 China: qPCR Reagents Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 52 China: qPCR Reagents Market Size, By End User, 2013-2020 (USD Million)
Table 53 China: qPCR Reagents Market Size, By Application, 2013-2020 (USD Million)
Table 54 India: qPCR Reagents Market Size, By Detection Method, 2013-2020 (USD Million)
Table 55 India: qPCR Reagents Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 56 India: qPCR Reagents Market Size, By End User, 2013-2020 (USD Million)
Table 57 India: qPCR Reagents Market Size, By Application, 2013-2020 (USD Million)
Table 58 RoAPAC: qPCR Reagents Market Size, By Detection Method, 2013-2020 (USD Million)
Table 59 RoAPAC: qPCR Reagents Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 60 RoAPAC: qPCR Reagents Market Size, By End User, 2013-2020 (USD Million)
Table 61 RoAPAC: qPCR Reagents Market Size, By Application, 2013-2020 (USD Million)
Table 62 RoW: qPCR Reagents Market Size, By Detection Method, 2013-2020 (USD Million)
Table 63 RoW: qPCR Reagents Market Size, By Packaging Type, 2013-2020 (USD Million)
Table 64 RoW: qPCR Reagents Market Size, By End User, 2013-2020 (USD Million)
Table 65 RoW: qPCR Reagents Market Size, By Application, 2013-2020 (USD Million)
Table 66 New Product Launches and Product Approvals, 2012–2015
Table 67 Agreements, Collaborations, and Partnerships, 2012–2015
Table 68 Mergers, Demergers, and Acquisitions, 2012–2015
Table 69 Geographical Expansions, 2012–2015
 
 
List of Figures (55 Figures)
 
Figure 1 Research Design
Figure 2 Healthcare Expenditure Across Key Markets, 2000 vs. 2012
Figure 3 Healthcare Spending Matrix: Key Markets, 2013
Figure 4 Global Rise in Proportion of Geriatric Population (2000–2013)
Figure 5 Increase in Aging Population, By Country, 2005 vs. 2010
Figure 6 Global Burden of Cancer, By Region, 2005–2030
Figure 7 Rising Incidence of Cancer Across Key Regions, 2008 vs. 2012
Figure 8 Annual Crude Birth Rate Across Key Global Markets, 2011
Figure 9 Prevalence of HIV Infections Across the Globe, By Region, 2013
Figure 10 Global Outbreak of Leading Infectious Diseases, 1980–2010
Figure 11 Rape and Homicide Cases Across Key Regions, 2003–2012
Figure 12 qPCR Products vs. PCR Market: A Comparative Study
Figure 13 Bottom-Up Approach
Figure 14 Top-Down Approach
Figure 15 Data Triangulation
Figure 16 Assumptions for the Research Study
Figure 17 North America is Expected to Dominate the Dye-Based and Probe & Primer-Based qPCR Reagents Markets By 2020
Figure 18 North America is Expected to Dominate the qPCR Core Kits & qPCR Master mixes Segments By 2020
Figure 19 Hospitals & Diagnostic Centers Segment Will Continue to Dominate the qPCR Reagents Market in 2020
Figure 20 North America is Expected to Dominate the qPCR Reagents Market During the Forecast Period
Figure 21 Top 3 Market Players to Hold ~3/4th Market Share of the qPCR Reagents Market (2014)
Figure 22 Attractive Growth Opportunities in the qPCR Reagents Market
Figure 23 North America is Expected to Dominate the Dye-Based and Probe & Primer-Based qPCR Reagents Markets Till 2020
Figure 24 U.S. is Expected to Dominate the qPCR Reagents Market in 2015
Figure 25 North America to Command the Largest Share of Key qPCR Reagent Application Segments in 2015
Figure 26 China and India to Lead the Market Demand for qPCR Reagents Among Key End Users During the Forecast Period
Figure 27 qPCR Reagents Market: Drivers, Restraints, Opportunities, & Challenges
Figure 28 HIV Prevalence, By Region, 2013
Figure 29 Incidence of New Cancer Cases Will Be High Among the Geriatric Population
Figure 30 Traditional PCR vs. qPCR: A Comparative Study
Figure 31 Percentage Change in Annual Healthcare Expenditure Developed vs. Developing Countries (2010–2012)
Figure 32 Value Chain Analysis (2014): Major Value is Added During the Manufacturing Phase
Figure 33 qPCR Reagents Market: Supply Chain (2014)
Figure 34 Presence of Large Number of New Entrants Increases Market Competition
Figure 35 Dye-Based Reagents to Dominate the qPCR Reagents Market Till 2020
Figure 36 qPCR Core Kits to Dominate the qPCR Reagents Market Revenue Till 2020
Figure 37 Hospitals & Diagnostic Centers to Dominate the qPCR Reagents End-User Market During Forecast Period (2015–2020)
Figure 38 North America to Dominate the qPCR Reagents Market for Forensic Laboratories
Figure 39 Diagnostic Applications to Dominate the qPCR Reagents Application Market Till 2020
Figure 40 North America: qPCR Reagents Market Trends (2015-2020)
Figure 41 Europe: qPCR Reagents Market Trends (2015-2020)
Figure 42 APAC: qPCR Reagents Market Trends (2015-2020)
Figure 43 Product Development & Commercialization Was Adopted By Most Leading Players During 2012-2015
Figure 44 Global qPCR Reagents Market Share Analysis, By Key Player (2014)
Figure 45 Majority of Leading Market Players are Focused on Product Launches and Approvals as Their Key Growth Strategy
Figure 46 Geographic Revenue Mix of the Top Five Market Players* (2014)
Figure 47 Leading Human qPCR Reagent Manufacturers Focused on Product Development & Commercialization to Strengthen Their Market Position
Figure 48 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 49 Bio-Rad Laboratories, Inc. : Company Snapshot
Figure 50 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 51 Qiagen N.V. : Company Snapshot
Figure 52 Agilent Technologies, Inc. : Company Snapshot
Figure 53 Takara Bio, Inc.: Company Snapshot
Figure 54 Affymetrix, Inc.: Company Snapshot
Figure 55 Sigma-Aldrich Corporation: Company Snapshot

The Global qPCR reagents market is poised to reach ~USD 1,893.9 Million by 2020 From USD 1,307.0 Million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome. However, technical limitations associated with qPCR are restraining the growth of this market.

On the basis of packaging type, the qPCR reagents market is classified into two major segments core kits and mastermixes. The qPCR core kits segment is expected to account for the largest share of the global market, by packaging type, in 2015. Its large share is propelled by factors such as low prices of core kits (as compared to mastermixes), flexibility offered to end users (as it is best suited for researchers to develop independent reaction protocols), growing private-public funding for life science research, and increasing market availability of qPCR core kits across major countries.

On the basis of end user, the market is classified into five segments hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, and forensic laboratories. The hospitals and diagnostic centers segment is expected to account for the largest market share of qPCR reagents market, in 2015. The dominant market position of hospitals and diagnostic centers can be attributed to strengthening healthcare infrastructure for efficient disease diagnosis & treatment, increasing number of qPCR reagents launched for diagnostic applications, and benefits offered by qPCR in disease diagnosis.

Geographically, the market is classified into four regions North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America is estimated to dominate the global market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to increasing penetration of global life sciences companies in this region, rising focus of governments on increasing the awareness about gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR technologies, and advancing cancer research in Japan.

Product development & commercialization, agreements, collaborations, and partnerships are the key strategies adopted by major players to strengthen their positions in the global qPCR reagents market. Moreover, strategies such as mergers, demergers, acquisitions, geographic expansions, and research funding & grants were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global market.

Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche, Ltd. (Switzerland), Agilent Technologies Inc. (U.S.), Takara Bio (Japan), Affymetrix Inc. (U.S.), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), and Quanta Biosciences Inc. (U.S.), are few of the key players operating in the global qPCR reagents market.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo